Global Alcohol Use Disorder Market

Market Snapshot

• Market Size (2025): USD 824.6Billion
• Projected Market Size (2035): USD 72.64Billion
• Compound Annual Growth Rate (CAGR): 8.83%
• Largest Regional Market: North America
• Fastest Growing Region: Asia Pacific
• 2^nd Largest Region: Europe
• Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2025–2035

According to Decision Advisors, the Global Alcohol Use Disorder Market Size is expected to grow from USD 824.6billion in 2025 to USD 1921.3 billion by 2035, at a CAGR of 8.83% during the forecast period 2025-2035. The global alcohol use disorder market experiences growth because multiple risk factors, including depression and anxiety, bipolar disorder, adverse childhood experiences and social influences continue to increase.

 

Market Overview/ Introduction

The alcohol use disorder (AUD) market refers to the global industry that develops methods for diagnosing, treating, and managing Alcohol Use Disorder, a chronic disorder that prevents people from stopping alcohol intake despite experiencing harmful effects on their social life, physical health and mental well-being. The AUD market grows because people drink more alcohol, mental health awareness increases and treatment options become more available. The market serves as an important solution for a significant worldwide public health problem because it helps people recover from drug abuse while preventing them from using drugs again, as shown by the 3 million annual deaths that result from dangerous alcohol consumption.

 

The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. DemeRx NB, Inc., which focuses on developing medications for alcohol and drug addiction treatment, started its oral dose study with healthy volunteer enrollment in June 2024. DemeRx is testing a medication called DMX-1001 in a Phase 1 clinical trial.

 

• Beckley Psytech announced successful Phase IIa trial results in January 2025 and demonstrated that BPL-003 reduced alcohol intake and heavy drinking days for three months after one-time administration.  

 

• The Alcohol Use Disorder treatment program of Lunai Bioworks started its operations in January 2026 after the company successfully produced detailed multidimensional behavioral patterns through its NIH STTR project. The Food and Drug Administration has authorized three drugs for alcohol use disorder treatment as of May 2024.

 

Notable Insights: -

1. North America holds the largest regional market share, approximately 40% in the global alcohol use disorder market.
2. Asia Pacific is the fastest-growing region in the global alcohol use disorder market.
3. By treatment type, the behavioral therapy segment held a dominant position of over 55% in terms of market share in 2025.
4. By route of administration, the electrocardiogram segment is the global market share in 2025.
5. The compound annual growth rate of the global alcohol use disorder market is 8.83%.
6. The market is likely to achieve a valuation of USD 1921.3billion by 2035.

 

 

What is the role of technology in grooming the market?

The alcohol use disorder (AUD) market undergoes a complete transformation through technological advancements, which enable better diagnostic methods and treatment options and enhanced patient care systems. Digital therapeutics and mobile health (mHealth) applications improve patient monitoring capabilities while maintaining treatment compliance, which leads to a 20-30% increase in successful treatment outcomes. Telemedicine platforms have expanded access to care, especially in remote areas, boosting treatment reach by 25%. The use of artificial intelligence (AI) together with data analytics enables organizations to discover high-risk individuals while developing customized treatment strategies, which result in a 15-20% improvement in clinical results. Wearable devices monitor alcohol consumption habits and body signals, which allows for a prompt medical response. Biotechnology and precision medicine have transformed drug development processes by introducing innovative solutions that decrease development timeframes by 10 to 15%. Moreover, electronic health records (EHRs) provide organizations with efficient methods to handle patient information, which results in enhanced efficiency for medical teams. The Alcohol Use Disorder market experiences substantial growth and innovation because more than 400 million people require treatment, while technological progress improves operational effectiveness and service delivery, and treatment outcomes.

 

Market Drivers

The global alcohol use disorder market is driven by the growing number of alcohol dependence cases, which currently affect millions of people from multiple regions who experience lifestyle-related stress, mental health issues, and rising alcohol usage. Public health campaigns and better screening methods have created a system that enables people to recognize and diagnose medical conditions at an earlier stage. The combined research progress in medication development and digital health technologies, including telemedicine and AI-driven monitoring systems, has created new treatment methods that improve both patient access and medication compliance. The introduction of new products serves as a vital component that drives market growth. The development of genetically targeted drugs (like AD04) and new intranasal treatment formulations (BPL-003) enables researchers to create more effective therapies, which result in better patient results.

 

Restrain

The main restraints on the global alcohol use disorder market include the as social stigma, which prevents people from seeking treatment, resulting in underdiagnosis through unreported cases. High treatment costs and limited access in low-income regions hinder growth. The market expansion gets restricted because of two factors, which are poor medication adherence and the demanding process for new therapy approvals.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the alcohol use disorder market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in Global Alcohol Use Disorder Market

1. Alkermes plc
2. Pfizer Inc.
3. H. Lundbeck A/S
4. GlaxoSmithKline plc
5. Teva Pharmaceutical Industries Ltd.
6. Otsuka Pharmaceutical Co., Ltd.
7. Indivior PLC
8. Sanofi S.A.
9. Novartis AG
10. Merck & Co., Inc.

 

Government Initiatives

Country	Key Government Initiatives
US	The Substance Abuse and Mental Health Services Administration leads national efforts through funding, awareness, and treatment programs for Alcohol Use Disorder (AUD). The National Drug Control Strategy and Medicaid expansion improve access to rehabilitation and medications like Naltrexone. The U.S. invests over $40 billion annually in substance abuse prevention and treatment, boosting market growth.
China	The National Health Commission of China promotes mental health reforms and addiction treatment programs. Policies under the Healthy China 2030 initiative emphasize substance abuse prevention. Increasing hospital-based treatment facilities and awareness campaigns are expanding access, driving growth in the AUD treatment market.
India	The Ministry of Social Justice and Empowerment runs the National Action Plan for Drug Demand Reduction (NAPDDR), supporting rehabilitation centers and awareness programs. Government-backed de-addiction centers and campaigns target millions affected by alcohol misuse, improving treatment accessibility and increasing demand in the AUD market
UK	The National Health Service provides free or subsidized AUD treatment, including counseling and detox services. Government policies like the Alcohol Strategy focus on reducing harmful drinking. Public health campaigns and community-based interventions increase early diagnosis and treatment demand, supporting steady market expansion.

 

Market Segmentation

The alcohol use disorder market share is classified into treatment type, route of administration, and end user. 

 

• The behavioral therapy segment dominated the market in 2025, and is projected to grow at a substantial CAGR of approximately 55% during the forecast period.

Based on the treatment modalities, the alcohol use disorder market is divided into pharmacological treatment, behavioral therapy, counseling & rehabilitation programs. Among these, the behavioral therapy segment dominated the market in 2025 and is projected to grow at a substantial CAGR of approximately 55% during the forecast period. The growth of the segment is driven by the need for this evaluation process to be verified through their long-term success and their implementation across treatment facilities. The process needs these three elements because recovery from substance use disorders requires both psychological therapy and medication treatment, and organized rehabilitation programs.

 

 

• The oral segment accounted for the largest share in 2025, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the route of administration, the alcohol use disorder market is divided into oral, injectable. Among these, the oral segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period. The majority share results from easy administration combined with high patient compliance. Naltrexone and Acamprosate become widely prescribed medications because they offer cost-effective solutions that work for extended outpatient treatment needs.

 

• The hospitals & clinics segment dominated the market in 2025, and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the alcohol use disorder market is divided into hospitals & clinics, specialty addiction treatment centers, homecare settings. Among these, the hospitals & clinics segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period. Accounting for the highest share of alcohol use disorder treatment. The medical supervision and detoxification services, and prescription therapies create a situation where people can access treatment. The combination of increased patient numbers, improved hospital facilities and expanded insurance coverage results in hospitals becoming the main healthcare facilities while specialty centers and home care settings serve as secondary options.

 

Regional Segment Analysis of the Alcohol Use Disorder Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the alcohol use disorder market over the predicted timeframe.

North America is anticipated to hold the largest share of the alcohol use disorder market over the predicted timeframe. This market is accounting about approximately 40% of the total market share. This dominance is driven by the high alcohol consumption rates, combined with advanced healthcare infrastructure and effective awareness programs, which create a better environment for treatment. The treatment market experiences growth because key players exist, and Naltrexone and Acamprosate treatments are widely available. The combination of favorable reimbursement policies and government initiatives creates better access to treatment for patients. The region strengthens its market position through product launches, which include innovative long-acting injectable formulations and digital therapeutics that enhance patient treatment compliance and results. North America maintains its market leadership position in the AUD industry because of ongoing research and development activities and its early acceptance of innovative treatment solutions.

 

Asia Pacific is expected to grow at a rapid CAGR in the alcohol use disorder market during the forecast period. The Asia-Pacific region is the fastest-growing market in the Alcohol Use Disorder (AUD) sector, driven by rising alcohol consumption and increasing awareness, with better healthcare facilities is driving alcohol use disorder treatment demand in China and India, which experiences faster treatment growth than the worldwide average. The regional development process receives acceleration from both expanding government programs and increasing public understanding of mental health issues. The introduction of new products by companies is driving market growth through their development of cost-effective generic medications, extended-release injectable products, and digital health solutions, which they designed for extensive patient populations

 

Europe is the 2^nd largest region to grow in the Alcohol Use Disorder market during the period. It holds a significant share due to high alcohol consumption rates, well-established healthcare systems, and strong government support for addiction treatment. Countries like Germany, the UK, and France contribute heavily, with widespread access to rehabilitation services and medications, ensuring steady market growth.

 

Strategies to Implement for Growth of the Market in Non-Leading Regions

To drive growth of the alcohol use disorder (AUD) market in non-leading regions such as Asia-Pacific, Latin America, and Africa, several targeted strategies are essential. Awareness campaigns need to expand their reach because developing areas experience more than 60% of their AUD cases not diagnosed, which creates treatment shortages. The organization needs to establish accessible healthcare solutions through permanent access to affordable treatment options, which include low-cost generics and community-based rehabilitation services that decrease therapy expenses by 20 to 30%. The third solution requires governments to establish stronger public-private partnerships for infrastructure development and outreach program expansion. The implementation of telemedicine and mobile applications as digital health solutions will extend treatment access by 25% to underserved rural populations. The process needs to train healthcare professionals while simultaneously decreasing social stigma because both elements work together to enhance diagnosis and patient engagement efforts. The implementation of localized product launches through the introduction of culturally adapted therapies and medications that require simple administration will improve product acceptance. The combined implementation of these strategies will enable sustainable expansion of the AUD markets, which currently lack sufficient service.

 

Future Market Trends in Global Alcohol Use Disorder Market: -

1.Rise of digital therapeutics and telehealth

The rise of digital therapeutics and telehealth is transforming the Alcohol Use Disorder market by improving accessibility and treatment adherence. Mobile apps, virtual counseling, and remote monitoring increase patient engagement by 20–30%. These technologies expand care reach, especially in underserved regions, driving demand for innovative, cost-effective AUD treatment solutions.

 

2. Adoption of AI-driven predictive analytics

Adoption of AI-driven predictive analytics in the Alcohol Use Disorder (AUD) market is enhancing early diagnosis and personalized treatment. AI analyzes patient data to predict relapse risks, improving outcomes by 15–20%. It also optimizes treatment plans and resource allocation, increasing efficiency and supporting better patient monitoring and long-term recovery success rates.

 

3. Precision medicine and genetically-based treatments

Precision medicine and genetically-based treatments are transforming the Alcohol Use Disorder (AUD) market by enabling personalized therapies based on genetic profiles. These approaches improve treatment success rates by 15–25%, reduce relapse risk, and support targeted drug development, driving innovation and increasing adoption of more effective, patient-specific AUD treatment solutions.

 

Recent Development

In November 2025, BrainsWay Ltd., a global leader in advanced noninvasive brain stimulation technologies, announced the launch of a multicenter clinical trial investigating the use of its novel Deep TMS 360 system in individuals with Alcohol Use Disorder (AUD).

 

In February 2025, Adial Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office had issued U.S. Patent No. 12,274,692, covering an innovative method for treating alcohol-related and opioid-related disorders using AD04 in genetically defined patient populations.

 

How is Recent Developments Helping the Market?

Recent developments are significantly advancing the alcohol use disorder (AUD) market through innovation, policy support, and improved access to care. New drug developments, including long-acting injectables and combination therapies, are enhancing treatment adherence and effectiveness by 20–30%. The rise of digital therapeutics and telehealth platforms has expanded treatment access by nearly 25%, especially in underserved areas. Governments are also increasing funding and launching awareness campaigns, boosting diagnosis rates. Additionally, ongoing research into genetically based and precision medicine therapies is improving patient-specific outcomes. These advancements collectively enhance accessibility, effectiveness, and patient engagement, driving sustained growth in the global AUD market.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the alcohol use disorder market based on the below-mentioned segments:  

 

Global Alcohol Use Disorder Market, By Treatment Type

• Pharmacological Treatment
• Behavioral Therapy
• Counseling & Rehabilitation Programs

 

Global Alcohol Use Disorder Market, By Route of Administration

• Oral
• Injectable

 

Global Alcohol Use Disorder Market, By End User

• Hospitals & Clinics
• Specialty Addiction Treatment Centers
• Homecare Settings

 

Global Alcohol Use Disorder Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ).

Q: What opportunities exist in the AUD market?

A: Opportunities include expansion in emerging markets, adoption of digital therapeutics, and development of personalized treatments. Innovations like long-acting injectables and AI-based monitoring tools improve patient outcomes. Increasing public-private partnerships and healthcare investments further enhance accessibility, creating strong growth potential in the global AUD market.

 

Q: How do medications help in treating AUD?

A: Medications like Naltrexone, Acamprosate, and Disulfiram reduce cravings, prevent relapse, or create aversion to alcohol. These drugs improve treatment success rates by 20–30% when combined with behavioral therapy, making pharmacological treatment a key component of AUD management.

 

Q: How is technology impacting the AUD market?

A: Technology is transforming the AUD market through telehealth, mobile apps, and AI-based monitoring. These tools improve treatment adherence by 20–30% and expand access by 25% in remote areas. Digital therapeutics and wearable devices also enable real-time tracking, enhancing early intervention and personalized treatment strategies.

 

Q: What role do rehabilitation centers play in the AUD market?

A: Rehabilitation centers provide structured treatment programs, including detoxification, counseling, and long-term recovery support. They are essential for severe AUD cases, offering controlled environments that improve recovery outcomes. These centers contribute significantly to the market by addressing relapse prevention and supporting sustained patient recovery.